American Vanguard Invests in TyraTech Natural Product Technologies

Wed Apr 3, 2013 9:00am EDT

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130403:nBw035378a

NEWPORT BEACH, Calif.--(Business Wire)--
American Vanguard Corporation (NYSE:AVD) today announced that it has completed
an investment in TyraTech, Inc. to participate in the continued development and
marketing of natural products for human and animal health applications. American
Vanguard has invested $3.7 million to secure a 29.46% ownership position in
TyraTech, Inc. 

American Vanguard`s equity investment achieves an important strategic objective
by expanding its involvement in the development of products derived from natural
sources and by participating in the penetration of such technologies in
non-agricultural market segments. TyraTech has developed more than a dozen
unique products that show efficacy as mosquito, fly, flea and tick repellents,
head lice control treatments and intestinal parasitic control agents. Several of
these products which are expected to be commercialized during 2013 and 2014
demonstrate performance characteristics that are superior to existing,
commercially available, offerings. The global addressable market potential for
such applications is estimated to be in the range of $8 to 10 billion annually. 

This investment follows the December 2012 creation of Envance Technologies, LLC
between AMVAC-Chemical Corporation (a wholly-owned subsidiary of American
Vanguard) and TyraTech, Inc. for the purpose of developing and commercializing
best-in-class technologies for the global consumer household and lawn & garden
retail markets. Envance Technologies, which is majority owned by AMVAC-Chemical,
already has its first commercial product line, Terminix Ultimate Protection, on
the shelves of a major U.S. retail home improvement chain. The global
addressable market potential for such products is estimated to be between $3.5
and 4.5 billion annually. Envance also expects to develop new combinations of
natural and synthetic compounds using TyraTech`s patented Extend Technology. 

Eric Wintemute, Chairman & CEO of American Vanguard Corporation commented: "This
investment solidifies our commitment to the development and commercialization of
effective human and animal health products derived from natural sources.
American Vanguard`s existing non-crop business addresses mosquito and
general-purpose commercial pest control with a proven chemical product
portfolio. TyraTech`s advanced technology and product formulations deploy
natural defenses for individual protection from many threats that can compromise
human and animal health. Our ownership stake in TyraTech joins us in a very
complementary mission, with a clearly aligned mutual interest in safeguarding
both public and personal health." 

Alan Reade, Executive Chairman of TyraTech, Inc, commented: "The commitment and
support of American Vanguard gives confidence in our strategy and credence to
our belief that we are in the right markets with the right products. We are
seeing a significant and growing desire for products which are natural, safer
and more effective within our markets and we aim to be at the forefront of this
transformational shift in demand. We are most grateful for American Vanguard`s
support, which provides a solid foundation from which we can build the TyraTech
business." 

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural
products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health.
American Vanguard is included on the Russell 2000 & Russell 3000 Indexes and the
Standard & Poors 600 Index. To learn more about American Vanguard, please
reference the Company`s web site at www.american-vanguard.com. 

About TyraTech

TyraTech, Inc. is a natural life sciences company that utilizes its proprietary
technology to develop solutions to address the unmet and increasing global
demand for effective, safe, and non-toxic insect and parasite technologies for
human and animal health. Founded in 2004, TyraTech made its Initial Public
Offering in June 2007 on the AIM section of the London Stock Exchange, where it
trades under the symbols TYR and TYRU. To learn more about TyraTech, please
visit the Company`s web site at www.tyratech.com.

American Vanguard Corporation
William A. Kuser, 949-260-1200
Director of Investor Relations
williamk@amvac-chemical.com
or
The Equity Group Inc.
Lena Cati, 212-836-9611
Lcati@equityny.com
www.theequitygroup.com



Copyright Business Wire 2013